U.S., Sept. 17 -- An application to own the trademark for 'MYOFORMIN' has been filed on Mar. 19, 2025.
Owner(s):
Emmyon, Inc.; 2746 Foxwoods Ln SW, , MINNESOTA
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of of skeletal muscle atrophy, sarcopenia, cachexia, muscular weakness, fatigue, obesity, diabetes, oncological disorders, hematological disorders, cancer, conditions associated with aging, heart failure, COPD, end stage renal failure, cirrhosis, critical illness, spinal cord injury, stroke, Parkinson’s disease, Alzheimer’s disease, rheumatoid arthritis, autoimmune disorders, Cushing’s syndrome, hypogonadism, osteoarthritis, orthopedic injuries, HIV/AIDS, chronic infection, diseases and conditions associate...